Hegira Health Inc Family Primary Care

Hegira Health Inc Family Primary Care

Services:
Facility Smoking Policy
• Smoking permitted in designated area

Ancillary Services

• Early intervention for HIV
• Integrated primary care services

Testing

• STD testing
• Testing for Hepatitis B (HBV)
• HIV testing
• Drug or alcohol urine screening
• Breathalyzer or blood alcohol testing
• Drug and alcohol oral fluid testing
• Testing for Hepatitis C (HCV)
• Metabolic syndrome monitoring

Education and Counseling Services

• Smoking/vaping/tobacco cessation counseling
• Hepatitis education, counseling, or support
• Substance use disorder education
• Health education services other than HIV/AIDS or hepatitis
• HIV or AIDS education, counseling, or support

External Source of Medications Used for Alcohol Use Disorder Treatment

• In-network prescribing entity
• No formal relationship with prescribing entity

Language Services

• Sign language services for the deaf and hard of hearing

Facility Operation (e.g., Private, Public)

• Private non-profit organization

Opioid Medications used in Treatment

• Buprenorphine used in Treatment
• Naltrexone used in Treatment

Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)

• Regular outpatient treatment
• Outpatient methadone/buprenorphine or naltrexone treatment
• Outpatient

Type of Opioid Treatment

• Buprenorphine maintenance
• Accepts clients using MAT but prescribed elsewhere
• Prescribes buprenorphine
• Relapse prevention with naltrexone
• Prescribes naltrexone

Transitional Services

• Aftercare/continuing care
• Outcome follow-up after discharge
• Naloxone and overdose education

Treatment Approaches

• Brief intervention
• Substance use disorder counseling
• Motivational interviewing
• Relapse prevention
• Telemedicine/telehealth therapy

Gender Accepted

• Male
• Female

Type of Care

• Substance use treatment

Type of Alcohol Use Disorder Treatment

• This facility administers/prescribes medication for alcohol use disorder

Assessment/Pre-treatment

• Professional interventionist/educational consultant
• Screening for substance use
• Comprehensive substance use assessment
• Screening for tobacco use
• Complete medical history/physical exam

Facility Vaping Policy

• Vaping permitted in designated area

Pharmacotherapies

• Disulfiram
• Nicotine replacement
• Lofexidine
• Naltrexone (extended-release, injectable)
• Buprenorphine (extended-release, injectable)
• Acamprosate (Campral®)
• Non-nicotine smoking/tobacco cessation
• Buprenorphine with naloxone
• Buprenorphine without naloxone
• Naltrexone (oral)
• Medications for Hepatitis C treatment

Payment Assistance Available

• Sliding fee scale (fee is based on income and other factors)
• Payment assistance (check with facility for details)

External Opioid Medications Source

• In-network prescribing entity
• No formal relationship with prescribing entity

License/Certification/Accreditation

• The Joint Commission
• State Substance use treatment agency

Payment/Insurance/Funding Accepted

• Federal, or any government funding for substance use treatment programs
• Medicare
• Cash or self-payment
• Medicaid
• Private health insurance
• State-financed health insurance plan other than Medicaid

Recovery Support Services

• Mentoring/peer support